Montella M, Crispo A, Grimaldi M, De Marco M R, Ascierto P A, Parasole R, Melucci M T, Silvestro P, Fabbrocini G
Epidemiology Unit, National Cancer Institute, Via Mariano Semmola, 80131 Naples, Italy.
Prev Med. 2002 Sep;35(3):271-7. doi: 10.1006/pmed.2002.1067.
Since survival of patients with melanoma is strongly correlated with the Breslow tumor thickness of the primary lesion, factors that influence stage at diagnosis and delay in diagnosis are considered to be crucial. To test the relationship between tumor thickness and some social and clinical variables (including diagnosis/treatment delay) and the relationship between the diagnosis/treatment delay and some clinical variables, we analyzed data on 530 patients with melanoma from our Institute.
In the analysis, Breslow tumor thickness was categorized into two categories (< or =1.49, > or =1.5). Three time intervals were examined to evaluate diagnostic delay: patient delay, time from first symptom to seeking medical advice; medical delay, time from first medical consultation to hospital admission; total delay, time from first symptom to resection. The variables evaluated in the analysis were: age at diagnosis, education, occupational status, first symptom, visibility of tumor, anatomic site, and physician who made the initial diagnosis.
A significant risk of having a Breslow tumor thickness > or =1.5 mm was noted in patients who had a low level of education (odds ratio 3.0, 95% confidence interval 1.9-5.0) or who were unemployed (odds ratio 1.7, 95% confidence interval 1.1-2.8). With respect to patient delay, a delay >3 months for anatomic locations visible to patients was associated with significant risk (odds ratio 1.7, 95% confidence interval 1.1-2.6); with respect to medical delay, a delay >3 months was associated with a higher risk in patients examined by a dermatologist (odds ratio 2.0, 95% confidence interval 1.2-3.4).
Our results clearly indicate that in Southern Italy poorly educated and unemployed subjects are at risk of being diagnosed at a more advanced stage, and admission to an oncological hospital causes a delay (waiting list) in the time interval related to the doctor (medical delay).
由于黑色素瘤患者的生存率与原发灶的 Breslow 肿瘤厚度密切相关,因此影响诊断分期和诊断延迟的因素被认为至关重要。为了检验肿瘤厚度与一些社会和临床变量(包括诊断/治疗延迟)之间的关系以及诊断/治疗延迟与一些临床变量之间的关系,我们分析了来自本院的 530 例黑色素瘤患者的数据。
在分析中,Breslow 肿瘤厚度被分为两类(≤1.49 和≥1.5)。检查了三个时间间隔以评估诊断延迟:患者延迟,即从首次出现症状到寻求医疗建议的时间;医疗延迟,即从首次就医咨询到住院的时间;总延迟,即从首次出现症状到切除的时间。分析中评估的变量包括:诊断时的年龄、教育程度、职业状况、首发症状、肿瘤可见性、解剖部位以及做出初步诊断的医生。
受教育程度低的患者(优势比 3.0,95%置信区间 1.9 - 5.0)或失业患者(优势比 1.7,95%置信区间 1.1 - 2.8)发生 Breslow 肿瘤厚度≥1.5 mm 的风险显著。关于患者延迟,患者可见的解剖部位延迟>3 个月与显著风险相关(优势比 1.7,95%置信区间 1.1 - 2.6);关于医疗延迟,皮肤科医生检查的患者延迟>3 个月与更高风险相关(优势比 2.0,95%置信区间 1.2 - 3.4)。
我们的结果清楚地表明,在意大利南部,受教育程度低和失业的人群有被诊断为更晚期的风险,并且入住肿瘤医院会导致与医生相关的时间间隔出现延迟(等候名单)(医疗延迟)。